Neogen (NEOG) Stock Analysis & AI Equity Report
Neogen (NEOG) overview
Neogen (NEOG) stock analysis and AI equity research. For financial year 2026, Valuatum's model shows revenue of USD 870m and operating profit of USD -21.6m; the year-end share price was 8.97 USD and market capitalisation was USD 1,953m. Neogen is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Neogen's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
About Neogen
Neogen develops, manufactures, and markets products and services for food and animal safety. Its food-safety offerings include diagnostic test kits, consumables, culture media, and software for detecting contaminants and assessing food quality, sold to producers, processors, laboratories, and regulatory agencies. Animal-safety products include veterinary instruments, medicines, vaccines, diagnostics, pest-control products, genomics testing, and drug-detection solutions distributed through industry channels.
Generate the Neogen report
Neogen is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Neogen and represent financial year 2026. See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.
Analyst reports on Neogen
Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.